HANNAH HIERLMAIER: Open Payments
NPI 1134900368 · REHOBOTH BEACH, DE. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$407 in 22 payments from 12 companies in 2025. Trend: 2023 $91 · 2024 $917 · 2025 $407
Food & beverage: $407
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 7 | $122 |
| ABBVIE INC. | 3 | $70 |
| AstraZeneca Pharmaceuticals LP | 3 | $53 |
| Lilly USA, LLC | 1 | $30 |
| PFIZER INC. | 1 | $19 |
| Novartis Pharmaceuticals Corporation | 1 | $19 |
| Cosette Pharmaceuticals Inc. | 1 | $17 |
| Tactile Systems Technology Inc | 1 | $17 |
| Abbott Laboratories | 1 | $16 |
| Astellas Pharma US Inc | 1 | $15 |
Products named: AIRSUPRA, MOUNJARO, Wegovy, QULIPTA, Ozempic, MAVYRET, NURTEC ODT, LEQVIO.
Industry payments across DE — which companies pay providers there.
